Abstract
Transgender women often seek hormone therapy to attain feminine physical features congruent with their gender identity. The aim of feminizing hormone therapy (FHT) is to provide suppression of endogenous testosterone and to maintain estradiol levels within the normal female range. Overall, FHT is safe if provided under supervision of an experienced health care provider and has been shown to improve quality of life. Data on care of transgender women are scarce and high-quality evidence-based recommendations are lacking. This article aims to review the published literature on FHT and provide guidance to clinicians caring for transgender women.
Original language | English (US) |
---|---|
Pages (from-to) | 341-355 |
Number of pages | 15 |
Journal | Endocrinology and Metabolism Clinics of North America |
Volume | 48 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2019 |
Keywords
- Anti-androgen
- Estrogen
- Gender dysphoria
- Gender incongruence
- Gender-affirming hormone therapy
- Transgender male-to-female
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology